Your browser doesn't support javascript.
loading
Application of Bayesian approaches in drug development: starting a virtuous cycle.
Ruberg, Stephen J; Beckers, Francois; Hemmings, Rob; Honig, Peter; Irony, Telba; LaVange, Lisa; Lieberman, Grazyna; Mayne, James; Moscicki, Richard.
Afiliação
  • Ruberg SJ; Analytix Thinking, Indianapolis, IN, USA. AnalytixThinking@gmail.com.
  • Beckers F; Merck KGaA, Darmstadt, Germany.
  • Hemmings R; Consilium Salmonson and Hemmings, Woking, UK.
  • Honig P; Independent Advisor, Collegeville, PA, USA.
  • Irony T; Janssen Pharmaceutical Companies of J & J, Titusville, NJ, USA.
  • LaVange L; University of North Carolina, Chapel Hill, NC, USA.
  • Lieberman G; Genentech, South San Francisco, CA, USA.
  • Mayne J; Pharmaceutical Research and Manufacturers of America, Washington, DC, USA.
  • Moscicki R; Pharmaceutical Research and Manufacturers of America, Washington, DC, USA.
Nat Rev Drug Discov ; 22(3): 235-250, 2023 03.
Article em En | MEDLINE | ID: mdl-36792750
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Indústria Farmacêutica Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Indústria Farmacêutica Idioma: En Ano de publicação: 2023 Tipo de documento: Article